A detailed history of Fieldpoint Private Securities, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 15 shares of CRSP stock, worth $614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 15 -0.0%
Holding current value
$614
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$110.2 - $156.64 $2,424 - $3,446
-22 Reduced 59.46%
15 $2,000
Q2 2021

Aug 12, 2021

SELL
$100.84 - $161.89 $403 - $647
-4 Reduced 9.76%
37 $5,000
Q1 2021

Apr 23, 2021

SELL
$110.72 - $210.04 $442,547 - $839,529
-3,997 Reduced 98.98%
41 $5,000
Q4 2020

Jan 28, 2021

SELL
$79.67 - $173.23 $62,222 - $135,292
-781 Reduced 16.21%
4,038 $618,000
Q3 2020

Oct 23, 2020

BUY
$78.5 - $100.64 $378,291 - $484,984
4,819 New
4,819 $403,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.19B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.